Technical Analysis for LCI - Lannett Co Inc

Grade Last Price % Change Price Change
grade F 6.0 0.00% 0.00
LCI closed unchanged on Monday, May 20, 2019, on 63 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical LCI trend table...

Date Alert Name Type % Chg
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Calm After Storm Range Contraction 0.00%
Narrow Range Bar Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Calm After Storm Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Up 3 Days in a Row Strength 0.00%
Up 4 Days in a Row Strength 0.00%

Older signals for LCI ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of branded pharmaceutical products in the United States. It offers solid oral, extended release, topical, and oral solution finished dosage forms of drugs that address a range of therapeutic areas. The company provides its products for various medical indications comprising glaucoma, migraine, antibiotic, anesthetic, endometriosis, irritable bowel syndrome, obesity, congestive heart failure, antipsychotic, pain management, thyroid deficiency, dryness of the mouth, epilepsy, gout, bronchospasms, hypertension, and gallstone. Lannett Company, Inc. markets its products under the Diamox, Fioricet, Fiorinal, Fiorinal w/ Codeine #3, Cleocin, Danocrine, Bentyl, Tenuate, Dospan, Lanoxin, Adoxa, Periostat, Prolixin, Dilaudid, Levoxyl, Synthroid, Loxitane, Adipex-P, Fastin, Salagen, Mysoline, Benemid, Rifadin, Brethine, Dyazide, and Actigall brands. It also manufactures active pharmaceutical ingredients. The company sells its pharmaceutical products to generic pharmaceutical distributors, drug wholesalers, chain drug retailers, private label distributors, mail-order pharmacies, other pharmaceutical manufacturers, managed care organizations, hospital buying groups, governmental entities, and health maintenance organizations. It has development and supply agreements with Azad Pharma AG, Swiss Caps of Switzerland, Pharma 2B, and the GC Group of Israel, as well as with Jerome Stevens Pharmaceuticals, Inc., Cerovene, and Summit Bioscience LLC. The company was founded in 1942 and is based in Philadelphia, Pennsylvania.
Health Pain Drugs Pharmaceutical Products Pharmaceutical Industry In China Pharmaceuticals Policy Obesity Pain Management Active Pharmaceutical Ingredients Glaucoma Hypertension Analgesics Epilepsy Pharmaceutical Manufacturers Generic Drug Irritable Bowel Syndrome Migraine Gout Congestive Heart Failure Drug Wholesalers Endometriosis Pharma Pharmaceutical Distributors
Is LCI a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 17.15
52 Week Low 3.33
Average Volume 1,335,727
200-Day Moving Average 6.7996
50-Day Moving Average 7.4858
20-Day Moving Average 7.025
10-Day Moving Average 6.329
Average True Range 0.5303
ADX 20.66
+DI 19.9865
-DI 31.7074
Chandelier Exit (Long, 3 ATRs ) 7.799100000000001
Chandelier Exit (Short, 3 ATRs ) 6.9865
Upper Bollinger Band 8.9341
Lower Bollinger Band 5.1159
Percent B (%b) 0.23
BandWidth 54.351601
MACD Line -0.5022
MACD Signal Line -0.3503
MACD Histogram -0.1519
Fundamentals Value
Market Cap 223.7 Million
Num Shares 37.3 Million
EPS -0.02
Price-to-Earnings (P/E) Ratio -300.00
Price-to-Sales 1.32
Price-to-Book 1.49
PEG Ratio -0.90
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 6.35
Resistance 3 (R3) 6.35 6.25 6.29
Resistance 2 (R2) 6.25 6.16 6.24 6.27
Resistance 1 (R1) 6.12 6.10 6.19 6.12 6.25
Pivot Point 6.02 6.02 6.05 6.01 6.02
Support 1 (S1) 5.89 5.93 5.96 5.89 5.75
Support 2 (S2) 5.79 5.87 5.78 5.73
Support 3 (S3) 5.66 5.79 5.71
Support 4 (S4) 5.66